Alnylam Pharmaceuticals (ALNY) Current Taxes (2009 - 2010)

Alnylam Pharmaceuticals' (ALNY) quarterly Current Taxes came in at $237000.0 in Q3 2010, down 12.87% on a QoQ basis from $272000.0 in Q2 2010.

Alnylam Pharmaceuticals (ALNY) Current Taxes (2009 - 2010) Analysis & Trends

Alnylam Pharmaceuticals (ALNY) has 2 years of Current Taxes data on file, last reported at $237000.0 in Q3 2010.

Quarterly Current Taxes changed N/A year-over-year to $237000.0 in Q3 2010, while the trailing twelve-month figure through Sep 2010 was $237000.0 (changed N/A YoY) and the FY2009 annual result came in at $5.5 million, changed N/A from the prior year.
Current Taxes declined to $237000.0 in Q3 2010, from $272000.0 in the prior quarter.
In the past five years, Current Taxes ranged from a high of $5.5 million in Q4 2009 to a low of $237000.0 in Q3 2010.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	49.00 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	76.32 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	59,089.99
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Roivant Sciences	26.16 Bn	26.85 Bn	1.16 Mn	74.18 Mn

Download Data